Why processors look closely at telehealth
Acquirers price risk around three questions: will the customer get what they paid for, will they dispute the payment, and could the acquirer be exposed to regulatory or reputational problems. Telehealth raises all three. Services are often sold on subscription, which increases disputes from customers who forget to cancel. Outcomes are subjective, so 'not as described' disputes are common. And anything touching medicine brings questions about licensing, prescribing and advertising claims.
None of this makes telehealth prohibited. It means the acquirer needs to understand exactly what is sold, who delivers it and under what licence, and how customers are billed. Mainstream self-serve processors are built for fast approvals and automated monitoring, so when a telehealth account triggers their review rules the easiest outcome for them is often to close it. Specialist acquirers are set up to review the model manually and price it properly instead.